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1596 PERKIN ET ALlife were independently and significantly associated with overall
nonadherence in the EIG. Enrollment eczema and enrollment
serum allergen-specific IgE sensitization to 1 or more foods
(>_0.1 kU/L) were not related to overall nonadherence. After
enrollment, 2 factors were significantly related to EIG overall
nonadherence: parent-reported IgE-type symptoms with infant
allergenic food consumption by 6 months of age and reported
feeding difficulties by 4 months of age.
Conclusion: If early introduction of allergenic foods were to be
considered a strategy to prevent food allergy, families of
nonwhite ethnicity, those with older mothers, and those with
infants with reported feeding difficulties or early-onset eczema
would benefit from support to promote early and sustained
consumption. (J Allergy Clin Immunol 2019;144:1595-605.)
Key words: Food allergy, diet, allergens, infancy, breastfeeding,
randomized controlled trial, adherence
The Enquiring About Tolerance (EAT) study was a large
randomized food allergy prevention trial of the early introduction
of 6 allergenic foods from 3 months of age in exclusively breast-
fed infants recruited from the general population.1,2 The EAT
study achieved markedly different rates of exposure to allergenic
foods between the randomized groups (the early introduction
group [EIG] and the standard introduction group [SIG]) before
6 months of age.1 However, the study did not show statistically
significant efficacy in an intention-to-treat analysis but did show
a significant per-protocol effect for allergy to 1 or more foods
and for egg and peanut individually.2
There are 2 explanations for this discrepancy. First, the per-
protocol analysis was effective because the population adhered to
the intervention. Second, the intention-to-treat analysis was not
effective because among the large group of children who did not
adhere to treatment, those with nascent allergy with food
sensitization had subclinical symptoms, food aversion, or both
and were therefore unable to adhere. Further analyses suggested
that food allergy prevention through early introduction of
multiple allergenic foods in normal breastfed infants might
depend on adherence and dosage.2
The EAT study per-protocol criteria for the EIG were stringent.
By 6 months of age, EIG infants were expected to have achieved
sustained high-dose consumption of 5 or more of the 6 early
introduction foods. Achieving such per-protocol adherence in the
EIG proved difficult. Only 42% (223/529) of adherence-evaluable
EIG children complied entirely with the protocol (34% (223/652)
of the whole EIG group).
After the completion of the study, we measured serum allergen-
specific IgE sensitization in the EAT participants and demonstrated
in an intention-to-treat analysis that the intervention successfully
reduced the development of food allergy among EIG infants who
were sensitized on specific IgE testing at enrollment. Infants with
the early emergence of food-specific IgE sensitization to foods are
known to be at high risk of developing a food allergy.3,4
In this article we explore how these and other data collected in
the EAT study influenced the issue of nonadherence to the
recommended level of consumption of the 6 early introduction
foods (overall nonadherence), as well as nonadherence to con-
sumption of individual foods (food-specific nonadherence). We
determined whether occult sensitization and early symptoms
were responsible for the high nonadherence rate.TheUKScientific Advisory Committee onNutrition has issued
the following statement after its review of the evidence on feeding
in the first year of life: ‘‘The available evidence indicates that the
deliberate exclusion or delayed introduction of peanut or hen’s
egg beyond 6 to 12 months of age may increase the risk of allergy
to the same foods.’’5 We address how barriers to the prompt intro-
duction of allergenic foodsmight bemitigated, thereby enhancing
the possibility of food allergy prevention.METHODS
Participants
One thousand three hundred three 3-month-old infants were recruited from
the general population in England and Wales through direct advertising and
were enrolled between November 2009 and July 2012. Details of the EAT
study methodology have been published elsewhere.1 Maternal age at
enrollment ranged from 19 to 46 years (median, 33 years), and there was no
difference in maternal age between study groups. The median age was used
as the cutoff for dividing mothers into younger (<33 years) and older
(>_33 years) groups. All children were generally well, exclusively breastfed,
and born at term (>_37 weeks’ gestation). Ethnic origin of the child was based
on their parent-defined ethnicity coded by using the classification used in the
2001 UK Census.6 One thousand one hundred four (84.7%) of the enrolled
infants were white, 119 (9.1%) were mixed, and 80 (6.1%) were black, Asian,
or Chinese. The trial was registered with the ISRCTN (registration no.
14254740). Ethical approval for the EAT study was provided by St Thomas’
Hospital REC (REC reference 08/H0802/93), and informed consent was
obtained from the parents of all children enrolled in the study.Procedures
Participants were randomized to the SIG or the EIG. The SIG was asked to
exclusively breastfeed to around 6 months of age in accordance with the
recommendation in place in the United Kingdom since 2003.7 Beyond
6 months, allergenic food consumption was at parental discretion.
The EIG parents were asked to introduce 6 allergenic foods to their infants:
cow’s milk (yogurt), peanut, cooked (boiled) hen’s egg, sesame, white fish,
and wheat.1 Cow’s milk was always introduced first as yogurt. The order of
introduction of the next 4 foods was randomly determined to avoid any bias
from one food being introduced consistently before another. Wheat was intro-
duced last and not before 4 months of age (see the ‘‘EIG early introduction
regimen’’ section in the Methods section in this article’s Online Repository
at www.jacionline.org).
An online questionnaire was sent to each family monthly to 1 year of age
and then every 3 months until the child reached 3 years of age. Each
questionnaire allowed families to report any suspected symptoms with food
ingestion and to list suspected foods. Clinical judgement was used to divide
these into IgE-type and non–IgE-type symptoms. The online questionnaires
also ascertained maternal quality of life using the World Health Organization
Quality of Life BREF questionnaire,8 infant sleep using the Brief Infant Sleep
Questionnaire,9 and parental reporting of feeding difficulty and aversive
feeding behavior by using questions based on previously published work.10
Clinic visits took place at enrollment and at 1 and 3 years of age. Further in-
formation on the online questionnaire and clinic visit data collected are pre-
sented in the ‘‘Information collected’’ section in the Methods section in this
article’s Online Repository.
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and at 1 and 3 years of age in both groups using ImmunoCAP (Phadia,
Uppsala, Sweden) assays. The primary outcome of the EAT study was the
proportion of participants with challenge-proved food allergy to 1 or more of
the 6 early introduction foods between 1 and 3 years of age.2Per-protocol adherence
The definitions of overall per-protocol adherence are presented in Table E1
in this article’s Online Repository at www.jacionline.org. The key criterion for
overall adherence in the EIG was consumption of at least 5 of the allergenic
foods in at least 75% of the recommended amount (3 g of allergen protein/
wk) for at least 5 weeks between 3 and 6months of age. Food-specific per-pro-
tocol adherence was based on the same criteria (ie, consumption of >_75% of
the recommended amount of the specific food for at least 5 weeks between
3 and 6months of age). Thewindow in which 5 or moreweeks of consumption
could be achieved was narrow, as explained in more detail in the ‘‘Restricted
window to achieve per-protocol status’’ section in the Methods section in this
article’s Online Repository.Statistical analyses
Univariate and multivariable logistic regression models were used to
identify factors associated with nonadherence. Penalized logistic regression
was used where appropriate for situations with very sparse data. Eczema was
analyzed as the presence of visible eczema at enrollment by using the UK
diagnostic criteria (‘‘visible eczema’’).11 Eczema severity was determined by
using the SCORAD index and grouped by using the accepted SCORAD cat-
egories.12 Data were analyzed with STATA software (version 15; StataCorp,
College Station, Tex), SAS software (version 9.4; SAS Institute, Cary, NC),
and JMP Pro 14 (SAS Institute). The EAT data set (ITN900AD) is available
through TrialShare, a public Web site managed by the Immune Tolerance
Network (www.itntrialshare.org).RESULTS
Overall per-protocol adherence status could only be deter-
mined in 81% (529/652) of the EIG participants (see Table E1).
An exploration of the likely true adherence status of the 123
EIG participants (19% of the EIG) whose adherence status was
nonevaluable, as well as the effect of including or excluding
them in the analyses undertaken for this article, are reviewed in
detail in the ‘‘EIG adherence nonevaluable participants’’ section
in the Results section and in Table E2 and Figs E1 and E2 in
this article’s Online Repository at www.jacionline.org.
Although overall adherence to the EAT early introduction
regimen was low at 42%, families found it easier to introduce
some foods than others (Fig 1), with the result being that food-
specific adherence varied by food: milk, 84% (451/537); peanut,
61% (336/549); whitefish, 59% (318/543); sesame, 52% (288/
550); egg, 42% (234/551); and wheat, 39% (216/553, see Table
E3 in this article’s Online Repository at www.jacionline.org).
Although randomization had been effective in ensuring the me-
dian age of introduction of peanut, egg, sesame, and fish was
the same at 19.6 weeks, there remained the possibility that the po-
sition in the order in which a specific food was introduced might
be associated with overall or food-specific adherence. Specific
foods introduced later in the sequence reduced the likelihood of
being per-protocol adherent to that food (see Fig E3 in this arti-
cle’s Online Repository at www.jacionline.org). However, the or-
der of introduction of each of the foods was unrelated to overall
per-protocol adherence.
The key period for defining per-protocol adherence was
consumption through 6 months of age. However, Fig 1 clearlyindicates that there were certain foods in which the ability to
meet the per-protocol threshold (3 g/wk of allergen protein)
continued to improve between 6 and 12 months of age. High sus-
tained levels of consumption were achieved by 6 months of age
for milk and shortly after 6 months of age for wheat. Per-
protocol consumption of fish and egg continued to improve
beyond 6 months, plateauing at 9 months for fish and 10 months
for egg. Most remarkable were the patterns observed for sesame
and peanut. The level of consumption of these 2 foods that had
been achieved by 6 months of age did not materially change
throughout the rest of the first year of life. Hence by 1 year of
age, therewas still a significant minority whowere not eating pea-
nut or sesame at the per-protocol recommended level.Enrollment factors associated with EIG overall and
food-specific nonadherence (univariate analysis)
Nonwhite ethnicity, increased maternal age, and lower enroll-
ment maternal quality-of-life scores were significantly associated
with not being per-protocol adherent in the EIG (see Table E4 in
this article’s Online Repository at www.jacionline.org for univar-
iate analysis). Nonwhite ethnicity and increased maternal age
were associated with delaying the introduction of solids in both
the SIG and EIG infants (see Fig E4 in this article’s Online Repos-
itory at www.jacionline.org). Differences were observed in other
enrollment demographic characteristics between ethnic groups:
visible eczema and enrollment sensitization were both more com-
mon in nonwhite ethnic groups, and a history of a sibling having a
parent-reported food allergy was more common in infants of
Asian, black, or Chinese ethnicity (see Table E5 in this article’s
Online Repository at www.jacionline.org) and are reviewed in
the ‘‘Association between ethnicity and baseline demographic
characteristics’’ in the Results section in this article’s Online
Repository.
Eczema severity (SCORAD as a continuous variable) was
significantly associated with overall nonadherence, whereas any
visible eczema at enrollment was of borderline significance
(P 5 .07, see Table E4). More details about the associations be-
tween enrollment factors and overall nonadherence are presented
in the ‘‘Enrollment factors associated with overall nonadherence’’
section in the Results section in this article’s Online Repository.
Associations between enrollment factors and food-specific non-
adherence are presented in the ‘‘Enrollment factors associated
with food-specific nonadherence’’ section in the Results section
in this article’s Online Repository.Enrollment sensitization in the EIG
In the EAT study therewere too few EIG participants sensitized
on skin prick testing at enrollment to individual foods (ranging
from none for sesame to 24 for raw egg white) to be able to
determine reliably the effect on subsequent food-specific adher-
ence (Table I). More EIG participants were shown to be sensitized
to specific foods based on serum food-specific IgE testing using a
0.1 kU/L threshold (response to >_1 foods of >_0.1 kU/L; 15.7%
[93/593]) than were identified to have positive skin prick test re-
sponses (>0 mm; 5.1% [33/652]; Table I).
Food-specific IgE sensitization at enrollment strongly
predicted the development of food allergy to the same food, and
sensitization to 1 or more foods strongly predicted overall food
allergy (see Fig E5 in this article’s Online Repository at
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FIG 1. Adherence with introduction of allergenic foods in the EIG up to 1 year of age. The figure presents the
relative proportions of the EIG consuming 100%, 75% (the per-protocol threshold), 50%, or 25% or not
having started consuming each of the 6 early introduction foods from enrollment through 12months of age.
The food-specific per-protocol adherence percentage (among those whose food-specific adherence status
was evaluable) is shown in parentheses.
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TABLE I. Enrollment sensitization data from the EAT study
Any food Peanut Egg Milk Sesame Fish Wheat
SPT >0 mm
EIG 5.1% (33/652) 1.2% (8/652) 3.7% (24/652) 1.4% (9/652) 0% (0/652) 0.2% (1/652) 0.2% (1/652)
EIG per-protocol 4.0% (9/223) 0.3% (1/336) 2.6% (6/234) 0.4% (2/451) 0% (0/288) 0% (0/318) 0% (0/216)
EIG non–per-protocol 4.0% (12/302) 1.9% (4/211) 4.4% (14/315) 4.9% (4/82) 0% (0/262) 0% (0/225) 0% (0/336)
EIG adherence nonevaluable 4.2% (5/120) 1.0% (1/103) 2.0% (2/101) 0% (0/115) 0% (0/102) 0% (0/109) 0% (0/99)
Specific IgE >_0.1 kU/L
All participants 15.6% (182/1170) 3.6% (42/1166) 6.7% (78/1170) 6.0% (70/1169) 2.0% (23/1151) 0% (0/1164) 4.3% (50/1165)
SIG 15.4% (89/577) 3.1% (18/576) 7.3% (42/577) 6.6% (38/576) 1.4% (8/572) 0% (0/575) 4.3% (25/576)
EIG 15.7% (93/593) 4.1% (24/590) 6.1% (36/593) 5.4% (32/593) 2.6% (15/579) 0% (0/589) 4.2% (25/589)
EIG per-protocol 13.6% (28/206) 2.3% (7/305)* 3.3% (7/214)* 3.9% (16/414) 2.3% (6/263) 0% (0/289) 5.5% (11/201)
EIG non–Per-protocol 15.4% (42/273) 5.7% (11/193) 8.0% (23/287) 8.3% (6/72) 3.1% (7/227) 0% (0/204) 3.7% (11/301)
EIG adherence nonevaluable 15.0% (16/107) 4.4% (4/90) 4.4% (4/90) 5.8% (6/103) 2.3% (2/89) 0% (0/96) 2.3% (2/86)
Specific IgE >_0.35 kU/L
All participants 6.4% (74/1170) 1.6% (19/1166) 3.9% (45/1170) 2.8% (33/1169) 0% (0/1151) 0% (0/1164) 0.9% (10/1165)
SIG 6.9% (40/577) 1.6% (9/576) 4.7% (27/577) 3.3% (19/576) 0% (0/572) 0% (0/575) 0.7% (4/576)
EIG 5.7% (34/593) 1.7% (10/590) 3.0% (18/593) 2.4% (14/593) 0% (0/579) 0% (0/589) 1.0% (6/589)
EIG per-protocol 2.9% (6/206) 0% (0/305)* 1.4% (3/214) 0.7% (3/414)* 0% (0/263) 0% (0/289) 0.5% (1/201)
EIG non–per-protocol 5.1% (14/273) 2.1% (4/193) 3.8% (11/287) 5.6% (4/72) 0% (0/227) 0% (0/204) 1.3% (4/301)
EIG adherence nonevaluable 6.5% (7/107) 4.4% (4/90) 2.2% (2/90) 2.9% (3/103) 0% (0/89) 0% (0/96) 0% (0/86)
Rows showing the EIG divided into the per-protocol, non–per-protocol, and adherence nonevaluable subgroups show overall adherence status for the any food column and food-
specific adherence status for individual food columns. Specific IgE levels were measured in 1170 children. However, some infants had very small amounts of serum obtained, and
all 6 individual foods could not be measured. Hence the denominator for individual foods varies (ranging from n 5 1151 for sesame to n 5 1170 for egg). The 7 EIG participants
who had positive enrollment challenge results to a food are excluded from the adherence rows (4 to milk, 1 to wheat, 2 to peanut, and 2 to egg) because they were unable to be
adherent being already allergic to the food.
SPT, Skin prick test.
*P < .05 and P < .01, P values for the EIG per-protocol and EIG non–per-protocol groups.
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FIG 2. EIG enrollment IgE sensitization and overall and food-specific per-protocol adherence. Penalized
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1 or more of the 6 early introduction foods and the association with food-specific and overall nonadherence
are shown.
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TABLE II. Logistic regression modelling of enrollment factors influencing EIG overall and food-specific nonadherence
EIG overall nonadherence
EIG-specific food nonadherence
Peanut Egg
OR P value OR P value OR P value
Ethnicity (nonwhite) 2.19 (1.13-4.25) .02 2.16 (1.20-3.91) .01 1.67 (0.90-3.10) .11
Visible eczema at enrollment (continuous SCORAD score) 1.02 (0.99-1.06) .16 1.02 (0.99-1.05) .21 1.02 (0.99-1.05) .27
QOL psychological domain (< mean) 1.51 (1.02-2.22) .04 1.17 (0.79-1.72) .44 1.21 (0.82-1.77) .34
Food-specific IgE at enrollment* (>_0.1 kU/L) 0.88 (0.48-1.60) .68 1.18 (0.39-3.59) .77 2.32 (0.85-6.31) .10
Maternal age (>_ median, 33 y) 1.59 (1.08-2.33) .02 1.85 (1.25-2.76) .002 2.32 (1.58-3.41) <.001
Nocturnal sleep duration at enrollment (h) 0.92 (0.79-1.06) .23 0.88 (0.76-1.01) .07 0.91 (0.79-1.04) .17
Nighttime awakenings at enrollment (no. of awakenings) 1.14 (0.97-1.34) .11 1.06 (0.91-1.25) .44 1.18 (1.01-1.39) .04
Parent-reported sleep problem at enrollment (none/small
problem/very serious problem)
1.11 (0.73-1.67) .63 1.27 (0.85-1.90) .25 0.87 (0.58-1.30) .49
OR, Odds ratio.
*Food-specific IgE (>_0.1 kU/L) to any food for EIG overall nonadherence and to the specific food for individual food-specific nonadherence. If sensitization status was included in
the model based on skin prick test response at enrollment, the result was statistically nonsignificant for overall nonadherence and food-specific nonadherence to any individual
food, with the exception of milk (positive milk skin prick test response: OR, 13.8; 95% CI, 1.68-112; P 5 .01). For each outcome, all the variables listed were included in the same
logistic regression model.
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allergy developing to other foods. The group of infants with early
food-specific IgE sensitization accounted for 69% of the food al-
lergy cases that developed in the EAT study. We have shown that
the EAT study early introduction intervention was effective in an
intention-to-treat analysis of this high-risk population.13
The great majority of EIG infants sensitized to a specific food
at enrollment did not report any symptoms when that food was
introduced into their diets (eg, 92% [18/22] for peanut).
Similarly, the great majority of infants whose families reported
symptoms with a specific food were not sensitized to that food at
enrollment (eg, 81% [17/21] for peanut). Both are reviewed in
detail in the ‘‘IgE-type symptom reporting and enrollment
sensitization’’ section in the Results section in this article’s On-
line Repository. Serum food-specific sensitization to 1 or more
foods did not predict overall nonadherence in the univariate
analysis (Fig 2). In contrast, in the univariate analysis food-
specific sensitization predicted food-specific nonadherence for
egg and was of borderline significance for peanut (Fig 2 and
see Fig E6 in this article’s Online Repository at www.
jacionline.org), both of which are likely to be a consequence
of the study design and discussed in more detail in the ‘‘Con-
sumption of each allergenic food by enrollment-specific IgE
sensitization status’’ section in the Results section in this arti-
cle’s Online Repository.Enrollment factors associated with EIG overall
nonadherence (multivariable analysis)
A multivariable analysis was undertaken to determine whether
overall nonadherence in the EIG could have been predicted from
certain enrollment characteristics (Table II, left column). There
was no significant relationship between enrollment sensitization
to 1 or more foods and overall nonadherence.
Nonwhite ethnicity, increased maternal age, and lower enroll-
ment maternal quality of life (psychological domain) all remained
significantly related to increased EIG overall nonadherence.
There was no statistically significant relationship with any
measure of eczema at enrollment, be this visible eczema, eczema
severity (SCORAD severity group), or SCORAD itself, although
all odds ratios were greater than 1.0.Enrollment factors associated with EIG food-
specific nonadherence (multivariable analysis)
Models were created for each individual food (Table II, other
columns). Results were broadly similar to overall nonadherence.
Ethnicity and maternal age were most strongly associated with
nonadherence. Enrollment eczema SCORAD was significantly
related to sesame and fish nonadherence but not to other foods.
In contrast to univariate associations, once potential confounding
factors were adjusted for, the relationship between enrollment
sensitization to any individual food and subsequent nonadherence
to these foods was attenuated (peanut odds ratio of 1.18 [95% CI,
0.39-3.59;P5.77] and egg odds ratio of 2.32 [95%CI, 0.85-6.31;
P 5 .10]) and not statistically significant. Among the other vari-
ables, nighttime waking frequency was significantly associated
with egg nonadherence.Postenrollment factors associated with
nonadherence (univariate analysis)
We explored 3 postenrollment factors in the key early
introduction period up to 6 months of age to assess their
association with nonadherence in the EIG (see Table E6 in this ar-
ticle’s Online Repository at www.jacionline.org). Thesewere new
onset of parent-reported eczema after enrollment but before
6 months, maternal reporting of feeding difficulties at the very
beginning of solid food introduction (assessed at 4 months of
age, see Table E7 in this article’s Online Repository at www.
jacionline.org), and reporting of IgE-type and non–IgE-type
symptoms with consumption of early introduction foods before
6 months of age (see Fig E7 and Table E8 in this article’s Online
Repository at www.jacionline.org). Although new-onset eczema
showed no association with overall or food-specific adherence,
there was a strong association between adherence and early re-
ported feeding difficulties and between adherence and the report-
ing of IgE-type symptoms to the early introduction foods in the
key early introduction period (Fig 3). The 3 factors are reviewed
in detail in the ‘‘Postenrollment factors associated with nonadher-
ence’’ section in the Results section in this article’s Online
Repository.
The association between reporting of IgE-type and non–IgE-
type symptoms and development of food allergy is reviewed in the
EIG-specific food nonadherence
Milk Sesame Fish Wheat
OR P value OR P value OR P value OR P value
1.67 (0.79-3.50) .18 1.68 (0.93-3.02) .08 2.06 (1.14-3.73) .02 1.68 (0.90-3.14) .10
1.01 (0.98-1.05) .41 1.04 (1.01-1.07) .02 1.04 (1.01-1.07) .01 1.01 (0.98-1.04) .43
0.99 (0.57-1.69) .96 1.06 (0.72-1.54) .77 1.02 (0.70-1.50) .91 1.42 (0.97-2.07) .07
1.33 (0.39-4.56) .65 0.94 (0.28-3.14) .92 — — 0.47 (0.18-1.24) .13
1.85 (1.04-3.30) .04 1.27 (0.87-1.85) .22 1.54 (1.04-2.27) .03 1.28 (0.88-1.87) .19
0.94 (0.78-1.14) .54 0.95 (0.83-1.09) .47 0.92 (0.80-1.06) .26 0.90 (0.79-1.04) .15
1.00 (0.81-1.25) .98 1.09 (0.93-1.27) .31 1.13 (0.97-1.32) .13 1.10 (0.93-1.29) .26
1.21 (0.69-2.10) .50 0.95 (0.64-1.42) .80 0.84 (0.56-1.26) .40 0.98 (0.66-1.46) .92
J ALLERGY CLIN IMMUNOL
VOLUME 144, NUMBER 6
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food introduction in the EIG and the effect on food allergy’’
section in the Results section and Fig E8 in this article’s Online
Repository at www.jacionline.org.Targeted intervention to reduce the overall food
allergy burden
The EAT study SIG participants can be used to explore the
natural history of the development of food allergy independent of
the early food introduction intervention. Children with visible
eczema or food sensitization at enrollment or those of nonwhite
ethnicity, although representing a small subgroup of the overall
population, contributed disproportionately to the burden of over-
all food allergy (Fig 4, A, and see Fig E9 in this article’s Online
Repository at www.jacionline.org).
SIG participants with eczema at enrollment made up 24.3% of
the study population but were responsible for 61.9% of the food
allergy cases. Likewise, 15.6% of the SIG were sensitized on IgE
testing at baseline to 1 or more foods but were responsible for
69.2% of food allergy cases in the SIG. Of the SIG, 15.3%were of
nonwhite ethnicity but accounted for 28.6% of food allergy cases
in the SIG, and a significantly greater proportion of nonwhite
participants had visible eczema and/or IgE food-specific sensiti-
zation at enrollment (see Table E5 and Fig E9). Furthermore, in
the EIG adherence was significantly lower in those participants
of nonwhite ethnicity (Fig 4, A).
We modelled the effects of improved adherence in infants at
high risk of developing food allergy (nonwhite infants, those with
enrollment eczema, or those with enrollment sensitization [>_0.1
kU/L]) and how this might affect the prevalence of food allergy
(Fig 4, B). Certain assumptions were made: an 80% intervention
effect was assumed given the high efficacy observed in the EAT
per-protocol analysis and the efficacy seen in the Learning Early
About Peanut Allergy (LEAP) study intention-to-treat analysis.14
Assuming that a greater level of adherence could be achieved in
these subgroups at high risk of developing food allergy than the
42% observed in the adherence-evaluable EIG children, we deter-
mined what the effect might be if an adherence rate of 85% is
assumed. Fig 4, B, displays the percentage reduction in totalallergy burden and the number needed to treat within the different
subgroups.
Targeting the intervention to the group of nonwhite and/or
eczematous infants would comprise a high-risk population of
71.4% of the food allergy burden. If 50%, 75%, or 85% adherence
rates can be achieved in this high-risk group, reduction in the
overall burden of food allergy in the whole population would be
approximately 29%, 43%, and 49%, respectively.DISCUSSION
Whilst 5.6% of EIG participants had a food allergy in the EAT
study, 58% were nonadherent with the early introduction proto-
col. Hence the nonadherence rate was 10-fold greater than the
food allergy rate. Notably, the nonadherence rate also signifi-
cantly exceeded the prevalence rate of risk factors associated with
developing a food allergy: visible eczema at enrollment (25%),
enrollment sensitization to 1 or more foods on specific IgE testing
(16%), and nonwhite ethnicity (15%).
In univariate analysis nonwhite ethnicity, older maternal age,
lower enrollment maternal quality-of-life scores, and increasing
SCORAD were associated with nonadherence to the EIG proto-
col. The enrollment factors that were found to remain signifi-
cantly associated with nonadherence in the adjusted analysis were
nonwhite ethnicity, older maternal age, and lower enrollment
maternal psychological quality of life. Nonwhite ethnicity and
older maternal age were associated in both study groups with
postponing the introduction of allergenic foods, compromising
the ability to be per-protocol adherent because the window for
per-protocol–defined adherence was so short. This delay being
present in the SIG could have been anticipated, having been
reported in the Infant Feeding Survey undertaken in 2010 (Infant
Feeding Survey 2010),15 and considered in more detail in the
‘‘Comparison with the Infant Feeding Survey 2010 findings’’ sec-
tion in the Discussion section in this article’s Online Repository at
www.jacionline.org. However, unexpectedly, this delay was pre-
sent in the EIG as well, despite all EIG families having being
asked to introduce the allergenic foods as rapidly as possible.
After enrollment, although the reporting of IgE-type symptoms
in EIG participants in the key early introduction period was
common (16%), this too fell far short of the 58% nonadherence
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FIG 3. Reporting in the key early introduction period (up to 6 months) of IgE-type symptoms to specific
foods, IgE-type or non–IgE-type symptoms to any of the early introduction foods, and the association with
food-specific and overall per-protocol adherence. Penalized logistic regression of the association between
symptoms with consumption of the 6 allergenic foods and food-specific and overall nonadherence.
Symptomsmanifesting by 6months of age are presented for IgE-type symptoms for each specific food, IgE-
type symptoms to 1 or more of the 6 early introduction foods, and non–IgE-type symptoms to 1 or more of
the 6 early introduction foods.
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such symptoms were neither sensitized to any food at enrollment
(76%) nor had a food allergy (82%). The strongest association
with nonadherence was the early emergence of feeding diffi-
culties, with 40% of non per-protocol EIG families reporting
some or great difficulty feeding their infant at 4 months of age
compared with 20% of the per-protocol EIG families.
Enrollment eczema was not associated with overall adher-
ence in the adjusted analyses (although it was associated with
food-specific adherence to sesame and fish). This is likely to
reflect the mild phenotype of infants with eczema in the EAT
study. Of the 160 EIG infants with enrollment eczema, in
123 it was mild (SCORAD <15), in 31 moderate (SCORAD
15 to <40), and in only 6 was it severe (SCORAD >_40).
Having eczema in childhood is strongly associated with
dietary restriction and a reluctance to include allergenic
foods in the diet. In a study of 100 children attending a
pediatric dermatology clinic, 75% were having some form of
parent-instigated dietary exclusion, and allergenic foods,
including dairy products, eggs, and cow’s milk, were being
omitted by 48%, 27%, and 25%, respectively.16
It might have been anticipated that enrollment sensitization
could lead to subclinical symptoms, resulting in a subclinical
form of pre-existing food allergy that prevented adherence. This
was not the case. Enrollment sensitization was not associated with
overall or food-specific adherence. Furthermore, the EAT inter-
vention was effective in an intention-to-treat analysis in the
enrollment-sensitized EIG infants.13The early emergence of parentally perceived feeding diffi-
culties and aversive feeding behavior by 4 months of age, when
families had only just started introducing solids to their EIG
infants, had the strongest associations with nonadherence in the
EIG and were also associated with later introduction of allergenic
foods. This finding suggests that families were trying to feed their
infants the allergenic food, but if the family perceived that the
infant was not ready or mature enough and theywere struggling to
achieve the study’s stipulated consumption levels, then, particu-
larly for certain foods and having reached a specific level of
consumption in the key early introduction period, they did not
attempt to escalate this level further beyond 6 months.
That infant maturity might be a key factor was demonstrated in
our recent analysis of sleep datawithin the cohort. In this studywe
showed in an intention-to-treat analysis that early introduction in
the EIG was associated with greater duration of sleep and fewer
night wakings, as well as significantly less parent-reported very
serious sleep problems.17 Notably, EIG infants whowere sleeping
better at enrollment were more likely to subsequently be per-
protocol adherent, suggesting that infant maturity is the link be-
tween the ability to sleep and eat better.17
Feeding difficulties were also shown in the Infant Feeding
Survey 2010 to have a strong association with ethnicity (consid-
ered in more detail in the ‘‘Comparison with the Infant Feeding
Survey 2010’’ section findings in the Discussion section in this ar-
ticle’s Online Repository).15 However, survey questions about
feeding difficulties in the context of a randomized controlled trial
in which the intervention sets high expectations for the
AB
FIG 4. Contributions of subgroups to the proportion of food allergy cases in the SIG. A, Bar charts provide
prevalence calculations used to estimate the reduction in total allergy burden and number needed to treat.
Per-protocol adherence rates are shown for those EIG participants whose adherence rates were evaluable
and also as a proportion of the whole EIG (percentages in parentheses). B, An 80% treatment effect and 85%
adherence across all risk factors for allergy is assumed. For example, infants in EAT with visible eczema
comprised 61.9% of the total food allergy burden. Hypothetically, if per-protocol adherence could be
achieved in 85% of this subgroup, then 52.6% (61.9%*85%) of the allergic burden would experience the
intervention. Moreover, if an intervention effect of 80% is assumed, then the total reduction in food allergy
that would be realized from intervening on this subgroup would be 42.1% (52.6%*80%).
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true feeding difficulties, which might be seen if a parent were left
to introduce solids at a time and in a way of their choosing.
The primary strength of this analysis is that the EAT study
cohort was recruited from the general population. The children
were meticulously studied and have been shown to have de-
mographic characteristics broadly similar to those of the popu-
lation of England and Wales.1 The potential weakness of our
findings is the extent towhich it can be concluded that factors per-
taining to the difficulty in following the highly prescriptive EAT
early introduction regimen might relate to the success of early
allergenic food introduction in the real world. However, we
have previously shown with modelling of our consumption data
that mean weekly consumption of 2 g of peanut protein (50%
of the recommended EAT weekly dose) was associated withprevention of peanut allergy, and a dose-response relationship
for protection against peanut allergy and egg allergy was
apparent.2
It has been recognized by others that when clinical efficacy has
been demonstrated in trials, such as EAT and particularly LEAP,
translating this into a public health intervention is complex, and
the results are likely to be subject to effect modification in
different populations.18 Hence the call for plausibility trials to
evaluate the effect of large-scale public health programs. Such tri-
als serve to identify the barriers and facilitators of the intervention
in the real world.18
Our findings suggest that there are certain groups who could
benefit from directed support should the recommendation of
early introduction of allergenic foods be adopted as a way to
prevent food allergy. Specifically, the important factors were
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with poorer quality of life. This also applies to infants with
early-onset eczema in that although their adherence to per-
protocol consumption of specific foods was not compromised
compared with children without eczema, it is within this group
that the majority of food allergy develops. Although these
factors explain only a small part of the 58% of EIG families
who were nonadherent, these groups of infants contributed
disproportionately to the overall prevalence of food allergy in
the EAT population. Indeed, our modelling shows that
improved adherence in infants manifesting early eczema and
from ethnic minorities raises the possibility of a substantial
reduction in the burden of food allergy, with a 49% reduction if
85% adherence were achievable. Sufficiently high adherence
rates with an early introduction regimen in these populations
will be more challenging yet of great value.
The issue of ethnic differences in adherence to public health
recommendations is well recognized.19 There is less of a literature
on ethnic differences in adherencewithin the context of a random-
ized trial in which subjects have consented to enroll.
A recent study of 1000 expecting and 1000 new caregivers of
infants less than 1 year of age reported questionable support for
early allergenic solid food recommendations.20 However, it has
been shown in Australia that updated guidelines issued in 2008
removing recommendations to delay allergenic solids have been
associated with reduced delay in parents introducing egg and pea-
nut into the diet.21 Cultural factors might well be important.
Although US caregivers can perceive early peanut introduction
to be difficult, the majority of Israeli infants are eating 2 g of pea-
nut protein per week without the support of guidelines or a public
health campaign.22
A number of countries, including the United States,23
Australia,24 and the United Kingdom,5,25,26 have issued new in-
fant feeding guidelines in light of the EAT and LEAP study find-
ings. Where a public health policy of early allergenic food
introduction is being recommended, a significant amount of pub-
lic health support is likely to be necessary to help specific groups
at risk of low adherence in order to achieve a substantial reduction
in the prevalence of food allergy.
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Clinical implications: Nonwhite families, those with older
mothers, and those with infants with early reported feeding dif-
ficulties or early-onset eczema would benefit from support to
achieve early and sustained allergenic food consumption.REFERENCES
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